Regent Peak Wealth Advisors LLC Buys New Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Regent Peak Wealth Advisors LLC bought a new stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 13,401 shares of the pharmacy operator’s stock, valued at approximately $125,000.

A number of other large investors have also recently bought and sold shares of the company. Sequoia Financial Advisors LLC lifted its position in shares of Walgreens Boots Alliance by 4.4% in the third quarter. Sequoia Financial Advisors LLC now owns 25,215 shares of the pharmacy operator’s stock worth $226,000 after purchasing an additional 1,063 shares in the last quarter. Lincluden Management Ltd. increased its stake in Walgreens Boots Alliance by 0.4% in the 3rd quarter. Lincluden Management Ltd. now owns 264,644 shares of the pharmacy operator’s stock valued at $2,371,000 after buying an additional 1,074 shares during the last quarter. CWA Asset Management Group LLC lifted its position in Walgreens Boots Alliance by 9.2% during the 4th quarter. CWA Asset Management Group LLC now owns 12,893 shares of the pharmacy operator’s stock worth $120,000 after buying an additional 1,084 shares in the last quarter. OLD Second National Bank of Aurora boosted its stake in shares of Walgreens Boots Alliance by 35.1% during the 3rd quarter. OLD Second National Bank of Aurora now owns 4,562 shares of the pharmacy operator’s stock worth $41,000 after buying an additional 1,185 shares during the last quarter. Finally, PFG Investments LLC grew its holdings in shares of Walgreens Boots Alliance by 3.8% in the 3rd quarter. PFG Investments LLC now owns 33,916 shares of the pharmacy operator’s stock valued at $304,000 after acquiring an additional 1,245 shares in the last quarter. Institutional investors and hedge funds own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Performance

Shares of WBA traded up $0.33 during midday trading on Tuesday, reaching $9.80. 10,540,592 shares of the stock were exchanged, compared to its average volume of 15,740,163. The company has a quick ratio of 0.37, a current ratio of 0.68 and a debt-to-equity ratio of 0.67. The stock’s 50 day simple moving average is $9.21 and its 200 day simple moving average is $9.97. Walgreens Boots Alliance, Inc. has a twelve month low of $8.08 and a twelve month high of $25.87. The company has a market cap of $8.46 billion, a P/E ratio of -0.98, a PEG ratio of 1.36 and a beta of 0.64.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.03. The business had revenue of $37.50 billion during the quarter, compared to analysts’ expectations of $35.75 billion. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The firm’s revenue for the quarter was up 5.9% compared to the same quarter last year. During the same period in the previous year, the company posted $0.67 earnings per share. On average, sell-side analysts expect that Walgreens Boots Alliance, Inc. will post 1.53 earnings per share for the current year.

Walgreens Boots Alliance Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, December 12th. Shareholders of record on Monday, November 18th were issued a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 10.20%. The ex-dividend date was Monday, November 18th. Walgreens Boots Alliance’s dividend payout ratio is currently -9.99%.

Analysts Set New Price Targets

WBA has been the topic of several analyst reports. Evercore ISI increased their price target on Walgreens Boots Alliance from $7.50 to $10.00 and gave the company an “in-line” rating in a research report on Wednesday, October 16th. Truist Financial cut their price objective on Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating for the company in a report on Monday, October 7th. UBS Group boosted their target price on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a report on Thursday, October 17th. Royal Bank of Canada cut their price target on shares of Walgreens Boots Alliance from $13.00 to $9.00 and set a “sector perform” rating for the company in a research note on Wednesday, December 4th. Finally, Morgan Stanley lowered their price objective on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating on the stock in a research note on Friday, October 11th. Four analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $12.58.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.